Sahyadri complements but does not compete with surrounding hospitals |Sahyadri forms an ideal HUB and SPOKE model where primary, secondary and tertiary health care is delivered with seamless integration |Sahyadri constantly endeavors to Innovate, Improvise and Indigenous Technology to make it affordable |Sahyadri has an attitude of Transparency, Respect and Compassion towards patients and their families to foster Reconciliation and Recuperation | "Sahyadri is the largest chain of hospitals in Maharashtra." |
First indigenous deep brain stimulator device in India.
Development of intraparenchymal probe for intracranial pressure monitoring.
Clinical Research Trials on Molecules for Chemotherapy, Control of fungal Infection in Immuno compromised patients and various innovative treatments for patients of Hemophillia. Research Paper of Dr. Anjali Kelkar “Detection of Minimal Residual disease in Acute Leukemia by Molecular Methods” was accepted by DBT.
Acute myleoid leukaemia
Patient with Factor VIII Inhibitor
Ca Head & Neck
Acute Ischaemic Stroke
Cardio and Vascular surgery
Clinical trial IV Cangrelor in PCI conducted in 2008-09
Diabetes Mellitus, Hypertension & Obesity
Schizophrenia, major depressive disorder & bipolar disorder.
A hoslistic musculoskeletal evaluation treatment and training program for hemophilia patients’ family members and physiotherapist - Dr. Rohini Dange by improving the musculoskeletal efficiency the musculoskeletal structure improves and reduces the number of bleeding episodes.
This improves the quality of life by training and educating the family member + training the neighborhood therapist with specialized therapy the patient will benefit from early stage, thus preventing the further damage.